Pluri Inc.

PLURNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.3M

▲ 309.8% YoY

Net Income

-$22.6M

▼ 8.1% YoY

EPS

$-3.56

▲ 10.8% YoY

Cash

$5.9M

▼ 13.1% YoY

FY 2025 · As of 2025-06-30

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.